Inflammatory bowel disease
ZAFIRO · Comprehensive pharmacotherapeutic follow-up model in inflammatory bowel disease (IBD)
SEFH-CSL Vifor 2025 Award for the quality of pharmacy services.
A care model that connects Hospital Pharmacy, Gastroenterology and Nursing in a single pathway for patients with IBD treated with biologics or small molecules. It combines longitudinal collection of PROMs through NAVETA (IBDQ-32, FACIT-Fatigue, TSQM, IBD-Control, WRFQ, P3CEQ) integrated into the electronic health record, stratification according to CMO-MAPEX, predictive machine learning models (Random Forest, Gradient Boosting), personalised feedback to the patient and automated drafting of the clinical progress note with generative AI. It incorporates actions from the SEFH Humanisation Guide (Family School and Satellite Clinic) and an FMEA of the digital pathway.
Population: 115 patients from 4 hospitals in the Balearic Islands, followed for 48 months.
Status: [pending]
